Results 141 to 150 of about 3,798 (162)
Pharmacological Management for Prevention and Treatment of Posthepatectomy Liver Failure.
Gerritsen A +6 more
europepmc +1 more source
Terlipressin: Current and emerging indications in chronic liver disease [PDF]
Terlipressin is an analogue of vasopressin that has potent vasoactive properties and has been available for use in most countries for nearly two decades.
Paul J Gow, Timothy Papaluca
exaly +2 more sources
BACKGROUND AND AIM: Terlipressin and somatostatin are the most preferable agents for the control of variceal bleeding in cirrhotic patients. The present study evaluated the hemodynamic effects of somatostatin, terlipressin and somatostatin plus ...
Epameinondas V Tsianos +1 more
exaly +1 more source
Effect of terlipressin on blood volume distribution in patients with cirrhosis
Udgivelsesdato: 2004-MayBACKGROUND: Patients with cirrhosis and portal hypertension have an altered blood volume distribution and a hyperdynamic systemic circulation.
Søren Møller +2 more
exaly +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis
Journal of Gastroenterology and Hepatology (Australia), 2009Choitsu Sakamoto +2 more
exaly
Time profile of the haemodynamic effects of terlipressin in portal hypertension
Journal of Hepatology, 1997Angels Escorsell
exaly
Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis
Journal of Hepatology, 2014Carlo Alessandria +2 more
exaly

